These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 6302550)
1. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3',5'-monophosphate phosphodiesterase inhibitors. Wachtel H Neuropharmacology; 1983 Mar; 22(3):267-72. PubMed ID: 6302550 [TBL] [Abstract][Full Text] [Related]
2. Rolipram, a novel antidepressant drug, reverses the hypothermia and hypokinesia of monoamine-depleted mice by an action beyond postsynaptic monoamine receptors. Wachtel H; Schneider HH Neuropharmacology; 1986 Oct; 25(10):1119-26. PubMed ID: 2946976 [TBL] [Abstract][Full Text] [Related]
3. Characteristic behavioural alterations in rats induced by rolipram and other selective adenosine cyclic 3', 5'-monophosphate phosphodiesterase inhibitors. Wachtel H Psychopharmacology (Berl); 1982; 77(4):309-16. PubMed ID: 6182575 [TBL] [Abstract][Full Text] [Related]
4. Species differences in behavioural effects of rolipram and other adenosine cyclic 3H, 5H-monophosphate phosphodiesterase inhibitors. Wachtel H J Neural Transm; 1983; 56(2-3):139-52. PubMed ID: 6190991 [TBL] [Abstract][Full Text] [Related]
5. Antidepressant properties of some phosphodiesterase inhibitors. Przegaliński E; Bigajska K Pol J Pharmacol Pharm; 1983; 35(3):233-40. PubMed ID: 6194518 [TBL] [Abstract][Full Text] [Related]
6. Neurotropic effects of the optical isomers of the selective adenosine cyclic 3',5'-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo. Wachtel H J Pharm Pharmacol; 1983 Jul; 35(7):440-4. PubMed ID: 6136585 [TBL] [Abstract][Full Text] [Related]
7. Effects of forskolin and cyclic nucleotides in animal models predictive of antidepressant activity: interactions with rolipram. Wachtel H; Löschmann PA Psychopharmacology (Berl); 1986; 90(4):430-5. PubMed ID: 3027733 [TBL] [Abstract][Full Text] [Related]
8. Involvement of rolipram-sensitive cyclic AMP phosphodiesterase in the regulation of cardiac contraction. Muller B; Lugnier C; Stoclet JC J Cardiovasc Pharmacol; 1990 Nov; 16(5):796-803. PubMed ID: 1703603 [TBL] [Abstract][Full Text] [Related]
9. Behavioral effects of rolipram and structurally related compounds in mice: behavioral sedation of cAMP phosphodiesterase inhibitors. Griebel G; Misslin R; Vogel E; Bourguignon JJ Pharmacol Biochem Behav; 1991 Jun; 39(2):321-3. PubMed ID: 1658815 [TBL] [Abstract][Full Text] [Related]
10. Antidepressant-like effects of rolipram and other inhibitors of cyclic adenosine monophosphate phosphodiesterase on behavior maintained by differential reinforcement of low response rate. O'Donnell JM J Pharmacol Exp Ther; 1993 Mar; 264(3):1168-78. PubMed ID: 8383740 [TBL] [Abstract][Full Text] [Related]
11. Effects of rolipram, a phosphodiesterase 4 inhibitor, in combination with imipramine on depressive behavior, CRE-binding activity and BDNF level in learned helplessness rats. Itoh T; Tokumura M; Abe K Eur J Pharmacol; 2004 Sep; 498(1-3):135-42. PubMed ID: 15363987 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of cyclic adenosine-3',5'-monophosphate phosphodiesterase from vascular smooth muscle by rolipram analogues. Marivet MC; Bourguignon JJ; Lugnier C; Mann A; Stoclet JC; Wermuth CG J Med Chem; 1989 Jul; 32(7):1450-7. PubMed ID: 2544722 [TBL] [Abstract][Full Text] [Related]
13. Discriminative stimulus effects of the type-4 phosphodiesterase inhibitor rolipram in rats. Makhay MM; Houslay MD; O'Donnell JM Psychopharmacology (Berl); 2001 Nov; 158(3):297-304. PubMed ID: 11713620 [TBL] [Abstract][Full Text] [Related]
14. The type IV phosphodiesterase inhibitors, Ro 20-1724 and rolipram, block the initiation of cocaine self-administration. Knapp CM; Foye MM; Ciraulo DA; Kornetsky C Pharmacol Biochem Behav; 1999 Jan; 62(1):151-8. PubMed ID: 9972858 [TBL] [Abstract][Full Text] [Related]
15. The pharmacodynamic action of the cyclic AMP phosphodiesterase inhibitor rolipram on prolactin producing rat pituitary adenoma (GH4C1) cells. Gordeladze JO Biosci Rep; 1990 Aug; 10(4):375-88. PubMed ID: 2174276 [TBL] [Abstract][Full Text] [Related]
17. Suppression of eosinophil function by RP 73401, a potent and selective inhibitor of cyclic AMP-specific phosphodiesterase: comparison with rolipram. Souness JE; Maslen C; Webber S; Foster M; Raeburn D; Palfreyman MN; Ashton MJ; Karlsson JA Br J Pharmacol; 1995 May; 115(1):39-46. PubMed ID: 7647982 [TBL] [Abstract][Full Text] [Related]
18. Close correlation between behavioural response and binding in vivo for inhibitors of the rolipram-sensitive phosphodiesterase. Schmiechen R; Schneider HH; Wachtel H Psychopharmacology (Berl); 1990; 102(1):17-20. PubMed ID: 2392503 [TBL] [Abstract][Full Text] [Related]
19. Isoprenaline induction of cAMP-phosphodiesterase in guinea-pig macrophages occurs in the presence, but not in the absence, of the phosphodiesterase type IV inhibitor rolipram. Kochetkova M; Burns FM; Souness JE Biochem Pharmacol; 1995 Dec; 50(12):2033-8. PubMed ID: 8849330 [TBL] [Abstract][Full Text] [Related]
20. Relaxation of guinea-pig trachea by cyclic AMP phosphodiesterase inhibitors and their enhancement by sodium nitroprusside. Turner NC; Lamb J; Worby A; Murray KJ Br J Pharmacol; 1994 Apr; 111(4):1047-52. PubMed ID: 8032589 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]